High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial.

Marrouche NF, Reddy RK, Wittkowsky AK, Bardy GH

Open source

DOI
10.1067/mhj.2000.106169
Published
2000 Jun
Container
American heart journal
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1067/mhj.2000.106169,
  title = {High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial.},
  author = {Marrouche NF and Reddy RK and Wittkowsky AK and Bardy GH},
  year = {2000},
  journal = {American heart journal},
  doi = {10.1067/mhj.2000.106169},
  url = {https://doi.org/10.1067/mhj.2000.106169}
}

RIS

TY  - JOUR
TI  - High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial.
AU  - Marrouche NF
AU  - Reddy RK
AU  - Wittkowsky AK
AU  - Bardy GH
PY  - 2000
JO  - American heart journal
DO  - 10.1067/mhj.2000.106169
UR  - https://doi.org/10.1067/mhj.2000.106169
ER  - 

APA

NF, M., RK, R., AK, W., & GH, B. (2000). High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial.. American heart journal. https://doi.org/10.1067/mhj.2000.106169

Source records